06.17.2025

German group Hella, part of Forvia conglomerate, the world’s seventh largest car supplier, continues operational reshuffling in Romania and announces, according to some market sources, the shutdown more

06.05.2025

State-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) has announced in a stock market report on June 5 that it recently won the 5th tender organized by the National Health Service (NHS), the more

06.03.2025

Irish retailer Primark has announced plans to open in 2026 its first store in Romania's northeastern city of Iasi, within the Palas Mall shopping center developed by IULIUS, as per a press statement more

05.14.2025

Pharma producer Antibiotice Iasi in the first quarter of this year generated total revenues of RON180 million, down 6%, and net profit of RON32.6 million, 13% lower than the year-earlier level. more

04.17.2025

Sphera Franchise Group (stock symbol: SFG), the company that manages KFC, Pizza Hut and Taco Bell restaurants in Romania, has informed the market in a report on April 17 about the opening of its third more

04.14.2025

US restaurant chain Popeyes will be opening its first restaurant in Romania's city of Iasi, in the new shopping center Moldova Mall, on April 17. more

04.08.2025

Outsourcing service provider Genpact Romania, the local subsidiary of the Indian group by the same name, continues investment in Iasi by opening a new delivery center, its officials said in a more

04.02.2025

The APAN Group, one of the largest car dealers in Moldavia, has invested EUR5 million in a Porsche service facility in Iasi, the third in the country, after Bucharest and Timisoara. more

03.25.2025

The Iulius Group will begin an extensive reconfiguration project at its Palas Iasi mixed-use complex, using a concept designed by Foster+ Partners, the first project by the famous international more

03.13.2025

Romanian drug manufacturer Antibiotice Iasi has proposed the distribution of RON13.8 million worth of dividends from the 2024 net profit reported on the basis of annual audited financial statements, more

02.26.2025

Romanian drug manufacturer Antibiotice Iasi in 2024 registered total revenues worth RON693 million, up 8%, and RON99 million net profit, 23% above the 2023 level. more

02.19.2025

ELI Parks, one of the most dynamic developers on Romania logistics and industrial market, has leased out phase one of ELI Park Iasi, which fills a 21,000-sqm area, and will further expand the project more

02.19.2025

Constructii Erbasu, a company owned by Erbasu family, in association with Iasi-based Conest, controlled by Viorel Cozma, have won a contract of around RON421.1 million (EUR84.6 million), VAT not more

01.27.2025

Developer Iulius is betting on the expansion of the Palas Iasi and on the start of its project in Constanta. more

01.22.2025

Uniprest Instal, a wholesaler of heating installations based in Targu-Mures and controlled by Dutch group Rensa, has signed a lease contract for 3,000 square meters within ELI Park Iasi. more

11.28.2024

Constructii Hidrotehnice Iasi (stock symbol: CHIA), specialized in hydrotechnics, has announced in a stock market report on Thursday, Nov 28, the signing of a contract worth RON23.13 million, which is more

10.21.2024

Dr. Max, a major player on Romania’s pharma market, has signed a leasing contract for 11,800 square meters in ELI Park Iasi, a project part of the portfolio of ELI Parks, one of the most dynamic more

10.02.2024

Romanian drug manufacturer Antibiotice Iasi has a RON850 million investment plan until 2030, covered through a funding mix, made up of cohesion funds, state aid, PNRR funds and EIB loan, stated more

09.17.2024

Hungary-based startup Munch, which provides an application designed to help curb food waste and entered the Romanian market this spring, is expanding operations in the country to Iasi, where it more

08.26.2024

Chemical producer and supplier Chimcomp0lex Borzesti (CRC.RO), which owns two industrial sites in Onesti and Ramnicu Valcea and is one of the largest entrepreneurial businesses in Romania, has more

08.19.2024

Oresa Industra currently has a 77,000-sqm portfolio concentrated in two logistic projects, a 35,000-sqm project in Iasi, and a 42,000-sqm one in Arad. more

08.14.2024

Romanian-owned drug manufacturer Antibiotice Iasi (stock symbol: ATB) ended the first half of 2024 with net profit of RON74 million, up 20% on the year, while its revenue rose by 8% to RON380 million, more

06.25.2024

Romania’s Grigore T. Popa University of Medicine and Pharmacy of Iasi (UMF Iasi) is borrowing EUR35.4 milion from the European Investment Bank (EIB) to refurbish and upgrade campus buildings. more

05.21.2024

Affidea, the largest player in the medical imaging services market in Romania, has completed the acquisition of MedEuropa radiotherapy centers, a deal announced in March 2024. The first step for the more

05.15.2024

Antibiotice Iasi, the largest Romanian-owned drug manufacturer, saw revenues reach an overall RON192.5 million level, 13% higher than in the year-earlier period. more